Eli Lilly and Company (LLY) financials · rev $65.18B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Eli Lilly and Company (LLY) rev $65.18B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $65.18B | $45.04B |
| Cost of Revenue | $11.05B | $8.42B |
| Gross Profit | $54.13B | $36.62B |
| Net Income | $20.64B | $10.59B |
| EPS (Diluted) | $22.95 | $11.71 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $112.48B | $78.71B |
| Current Assets | $55.63B | $32.74B |
| Cash & Equivalents | $7.27B | $3.27B |
| Inventory | $13.74B | $7.59B |
| PP&E | $24.68B | $17.10B |
| Total Liabilities | $85.94B | $64.52B |
| Current Liabilities | $35.23B | $28.38B |
| Short-term Debt | $1.64B | $5.12B |
| Long-term Debt | $40.87B | $28.53B |
| Total Debt | $42.50B† | $33.64B† |
| Shareholders' Equity | $26.54B | $14.19B |
| Retained Earnings | $24.47B | $13.54B |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $16.81B | $8.82B |
| Investing Cash Flow | -$10.97B | -$9.30B |
| Financing Cash Flow | -$2.21B | $1.23B |
| Dividends Paid | $5.38B | $4.68B |
| Net Change in Cash | $4.00B | $449.8M |
FAQ
What is LLY P/E and revenue?
Eli Lilly and Company (LLY) rev $65.18B.
What is LLY revenue?
Eli Lilly and Company last cached revenue is $65.18B (FY2025).
Is LLY profitable?
Eli Lilly and Company last cached net income is $20.64B (FY2025).
What are LLY total assets?
Eli Lilly and Company last cached total assets are $112.48B (FY2025).
What is LLY free cash flow?
No cached cash-flow row for LLY yet.
Not investment advice. Cached statements, not a live tape.